GILEAD PACT WITH 8 INDIAN COS FOR MANUFACTURING TENOFOVIR MAY TURN AGAINST PATIENTS: NGOS

The patients groups and health NGOs who have filed a pre-grant opposition against Gilead Science's patent application on tenofovir disoproxil fumarate, feel that the recent decision of Gilead to sign non-exclusive license agreements with eight generic companies of India can prove harmful to the long term interests of the patient groups in ensuring affordable medicines to the needy. Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=35310§ionid=)